Middle East & Africa Pregabalin Market Outlook

middle east and africa pregabalin market is expected to experience a significant growth in the coming years due to the rising prevalence of neurological disorders, such as epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. increase in geriatric population and the increasing awareness of medical conditions and treatment options are expected to drive the market growth over the forecast period. government initiatives to improve healthcare infrastructure and increase expenditure for the treatment of neurological disorders will further drive market growth. moreover, the development of the pregabalin market in the region is attributed to the entry of generics. moreover, presence of large unmet medical needs in emerging countries coupled with the presence of end-users and increasing number of generics manufacturers is expected to drive the market growth. furthermore, increasing adoption of advanced technology in healthcare sector is expected to further augment the demand of pregabalin in the region. the middle east & africa pregabalin market is highly competitive with a number of prominent market players. these companies are largely engaged in research & development activities to meet the demands of patients and develop newer drugs that can treat the various neurological disorders. moreover, the market players are also focusing on building networks with local vendors to upsurge their presence in domestic market and to supply the products in a cost-effective manner. for instance, in 2019, aurobindo pharma launched generic pregabalin tablets under the brand name lyrica cd in kuwait. the pregabalin market in middle east & africa is expected to witness a healthy growth over the forecast period owing to the rising demand of neurological disorders treatments, government initiatives to improve healthcare infrastructure, rising geriatric population, and increasing number of generic manufacturers. additionally, advancements in technology, increasing awareness of medical conditions and treatment options, and presence of large unmet medical needs in the emerging countries are the other key factors driving the market growth in the region.